Networking to reduce risk

While drug safety can be a source of competitive advantage, there is a greater mutual benefit in sharing experience and common challenges.  Drug safety people have many opportunities to network at a personal level and in an industry where there are numerous regulations and requirements that broaden and deepen on a daily basis, opportunities for debate with colleagues facing similar issues are vital.  There are national and regulatory working groups that enable people to meet and discuss the changing regulations. 

The conference circuit is another networking channel, however, although these avenues have proved invaluable for debating and creating a personal network, there is still a need to share actual data and compare detailed levels of activity.  With a further need to share ideas on how to tackle the hot issues - rising costs, signal detection and risk management, discuss trends and benchmark performance.  If you thought that you had a good process in a certain area, how could you be sure?  A more proactive approach was needed.    In response, in 2001 WCI founded pvnet. 

To read the case study in full, please click on the pdf link below:

Shaping the future of pharmacovigilance.pdf

or visit the pvnet and pvconnect websites at pvnet.wcigroup.com and pvconnect.wcigroup.com